Biomedical Engineering Reference
In-Depth Information
70. Amir-Aslani A, Mangematin V (2010) The future of drug discovery and development: shifting
emphasis towards personalized medicine. Technol Forecast Soc Change 77:203-217
71. Martel S, Mohammadi M, Felfoul O, Lu Z, Pouponneau P (2009) Flagellated magnetotactic
bacteria as controlled MRI-trackable propulsion and steering systems for medical nanorobots
operating in the human microvasculature. Int J Robot Res 28:571-582
72. Zderic V, Clark JI, Martin RW, Vaezy S (2004) Ultrasound-enhanced transcorneal drug
delivery. Cornea 23:804-811
73. Yanga W, Peters JI, Williams RO III (2008) Inhaled nanoparticles—a current review. Int J
Pharm 356:239-247
74. Ghosh Chaudhuri R, Paria S (2012) Core/shell nanoparticles: classes, properties, synthesis
mechanisms, characterization, and applications. Chem Rev 112:2373-2433
75. Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM (2006) Research
strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale
particles for toxicological evaluation. Toxicol Sci 90:296-303
76. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V,
Thompson M (2009) Understanding biophysicochemical interactions at the nano-bio interface.
Nat Mater 8:543-557
77. Kuna JJ, Voitchovsky K, Singh C, Jiang H, Mwenifumbo S, Ghorai PK, Stevens MM, Glotzer
SC, Stellacci F (2009) The effect of nanometre-scale structure on interfacial energy. Nat Mater
8:837-842
78. Monopoli MP, Aberg C, Salvati A, Dawson KA (2012) Biomolecular coronas provide the
biological identity of nanosized materials. Nat Nanotechnol 7:779-786
79. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nanotoday 3:40-47
80. Salata O (2004) Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2:3
81. Gaumet M, Vargas A, Gurny R, Delie F (2008) Nanoparticles for drug delivery: the need for
precision in reporting particle size parameters. Eur J Pharm Biopharm 69:1-9
82. Chellata F, Merhi Y, Moreau A, Yahia LH (2005) Therapeutic potential of nanoparticulate
systems for macrophage targeting. Biomaterials 26:7260-7275
83. Sun C, Lee JS, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv
Drug Deliv Rev 60:1252-1265
84. Breunig M, Bauer S, Goepferich A (2008) Polymers and nanoparticles: intelligent tools for
intracellular targeting? Eur J Pharm Biopharm 68:112-128
85. Mbeh DA, Franca R, Merhi Y, Zhang XF, Veres T, Sacher E, Yahia L (2012) In vitro
biocompatibility assessment of functionalized magnetite nanoparticles: biological and
cytotoxicological effects. J Biomed Mater Res Part A 100:1637-1646
86. Nel A, Xia T, M¨dler L, Li N (2006) Toxic potential of materials at the nanolevel. Science
311:622
87. Li N, Xia T, Nel AE (2008) The role of oxidative stress in ambient particulate matter-induced
lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol
Med 44:1689-1699
88. Huang YW, Wu CH, Aronstam RS (2010) Toxicity of transition metal oxide nanoparticles:
recent insights from in vitro studies. Materials 3:4842-4859
89. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Aschberger K, Stone V
(2010) A critical review of the biological mechanisms underlying the in vivo and in vitro
toxicity of carbon nanotubes:
the contribution of physico-chemical characteristics.
Nanotoxicology 4:207-246
90. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF (2010) Metal-based
nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol
2:544-568
91. Unfried K, Albrecht C, Klotz LO, Von Mikecz A, Grether-Beck S, Schins RPF (2007) Cellular
responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1:52-71
